HIPK2 neutralizes MDM2 inhibition rescuing p53 transcriptional activity and apoptotic function

Valeria Di Stefano1, Giovanni Blandino, Ada Sacchi

  • 1Department of Experimental Oncology, Molecular Oncogenesis Laboratory, Regina Elena Cancer Institute, Rome 00158, Italy.

Oncogene
|May 4, 2004
PubMed

Insights

The HIPK2 kinase overcomes MDM2 inhibition to activate the p53 tumor suppressor protein. This pathway restoration triggers apoptosis, crucial for suppressing tumor growth.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Cellular Signaling

Background:

  • The p53 oncosuppressor is negatively regulated by MDM2, inhibiting its activity.
  • Stress responses trigger p53 modifications, enabling it to evade MDM2 control and become active.

Purpose of the Study:

  • Investigate HIPK2's role in p53 activation when MDM2 is present.
  • Elucidate the mechanism by which HIPK2/p53 pathway suppresses tumorigenesis.

Main Methods:

  • In vitro and in vivo studies utilizing genotoxic stress models.
  • Analysis of p53 post-translational modifications and protein interactions.
  • Assessment of p53 transcriptional activity and apoptotic function.

Main Results:

  • HIPK2 kinase rescues p53 transcriptional activity, overcoming MDM2-mediated inhibition.
  • Restored p53 function induces apoptosis.
  • HIPK2 prevents MDM2-mediated p53 nuclear export and ubiquitination.

Conclusions:

  • HIPK2 plays a critical role in reactivating p53 function against MDM2 inhibition.
  • The HIPK2/p53 pathway promotes apoptosis by preventing p53 degradation and nuclear export.
  • This mechanism is vital for tumor suppression and offers therapeutic insights.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...